Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Yocca Frank
Chief Scientific Officer at BioXcel Therapeutics. Filing since 29 Nov 2018.
CIK 0001733272
Company
Date
Role
Action
Shares
Amount
Of holding
BTAI
BioXcel Therapeutics, Inc.
20 May 2026
Chief Scientific Officer
Sold on a plan
6,845
$7.43K
20.7%
BTAI
BioXcel Therapeutics, Inc.
16 Dec 2024
Chief Scientific Officer
Sold on a plan
430
$151.82
1.5%
BTAI
BioXcel Therapeutics, Inc.
3 Oct 2024
Chief Scientific Officer
Sold on a plan
7,175
$3.95K
20.2%
BTAI
BioXcel Therapeutics, Inc.
16 Sep 2024
Chief Scientific Officer
Sold on a plan
355
$244.70
2.4%
BTAI
BioXcel Therapeutics, Inc.
17 Jun 2024
Chief Scientific Officer
Sold on a plan
372
$476.16
2.7%
BTAI
BioXcel Therapeutics, Inc.
4 Apr 2024
Chief Scientific Officer
Sold on a plan
1,067
$2.81K
7.7%
BTAI
BioXcel Therapeutics, Inc.
15 Mar 2023
Chief Scientific Officer
Sold, plan not stated
985
$19.40K
9.4%
BTAI
BioXcel Therapeutics, Inc.
20 Jan 2023
Chief Scientific Officer
Sold, plan not stated
50,000
$1.50M
85.6%
BTAI
BioXcel Therapeutics, Inc.
15 Mar 2021
Chief Scientific Officer
Sold, plan not stated
15,000
$727.57K
20.4%
BTAI
BioXcel Therapeutics, Inc.
16 Feb 2021
Chief Scientific Officer
Sold, plan not stated
15,000
$865.15K
17.0%
BTAI
BioXcel Therapeutics, Inc.
25 Jan 2021
Chief Scientific Officer
Sold, plan not stated
15,000
$725.81K
14.5%
BTAI
BioXcel Therapeutics, Inc.
13 Aug 2019
Chief Scientific Officer
Bought
6,547
$56.76K
354%
BTAI
BioXcel Therapeutics, Inc.
4 Dec 2018
Chief Scientific Officer
Bought
450
$2.34K
32.1%
BTAI
BioXcel Therapeutics, Inc.
3 Dec 2018
Chief Scientific Officer
Bought
450
$2.35K
47.4%
BTAI
BioXcel Therapeutics, Inc.
30 Nov 2018
Chief Scientific Officer
Bought
450
$2.34K
90.0%
BTAI
BioXcel Therapeutics, Inc.
29 Nov 2018
Chief Scientific Officer
Bought
500
$2.51K
opened
16 decisions on file.
